Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Catecholamine-induced lipolysis in obesity.

P Arner1

  • 1Department of Medicine, Karolinska Institute at Huddinge University Hospital, Sweden.

International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|April 8, 1999
PubMed
Summary

Obesity causes resistance to catecholamine fat breakdown in subcutaneous fat but increases it in visceral fat. This redistribution favors visceral fat, potentially altering liver function and contributing to metabolic issues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term changes in adipose tissue gene expression following bariatric surgery.

Journal of internal medicine·2020
Same author

Adipose lipid turnover and long-term changes in body weight.

Nature medicine·2019
Same author

Epigenetic regulation of diabetogenic adipose morphology.

Molecular metabolism·2019
Same author

Insulin action is severely impaired in adipocytes of apparently healthy overweight and obese subjects.

Journal of internal medicine·2019
Same author

Improved metabolism and body composition beyond normal levels following gastric bypass surgery: a longitudinal study.

Journal of internal medicine·2018
Same author

Family history of diabetes is associated with enhanced adipose lipolysis: Evidence for the implication of epigenetic factors.

Diabetes & metabolism·2017

Area of Science:

  • Endocrinology
  • Metabolism
  • Obesity Research

Background:

  • Catecholamines are key hormones for lipolysis (fat breakdown) in humans.
  • Obesity is associated with altered catecholamine signaling in adipose tissue.
  • Subcutaneous adipose tissue, the primary fat depot in obesity, exhibits lipolytic resistance to catecholamines.

Purpose of the Study:

  • To investigate the differential effects of catecholamines on lipolysis in subcutaneous versus visceral adipose tissue in obesity.
  • To explore the underlying molecular mechanisms contributing to altered lipolysis in obesity.
  • To understand the implications of regional fat mobilization for metabolic health.

Main Methods:

  • In vivo and in vitro studies examining catecholamine signal transduction pathways.

Related Experiment Videos

  • Analysis of adrenoceptor expression and function (beta2, alpha2, beta3).
  • Assessment of cyclic AMP (cAMP) mediated stimulation of hormone-sensitive lipase (HSL).
  • Investigation of genetic factors, including gene polymorphisms, associated with obesity and lipolysis.

    • Main Results:

    • Subcutaneous adipose tissue shows reduced beta2-adrenoceptor function, increased alpha2-adrenoceptor function, and decreased cAMP-stimulated HSL activity, leading to catecholamine resistance.
    • Visceral adipose tissue exhibits increased beta3-adrenoceptor function, decreased alpha2-adrenoceptor function, and enhanced cAMP-stimulated lipolysis.
    • Genetic factors like polymorphisms in beta-adrenoceptor and HSL genes are linked to obesity.

    Conclusions:

    • Obesity causes a redistribution of lipolysis, favoring visceral fat mobilization over subcutaneous fat.
    • Increased visceral lipolysis elevates portal vein fatty acid levels, potentially leading to liver dysfunction, hyperinsulinemia, hyperglycemia, and dyslipidemia.
    • Understanding these regional differences in lipolysis is crucial for comprehending obesity-related metabolic complications.